IL6 and COVID-19: Studies have shown that increased inflammatory markers such as IL-2, IL-6, macrophage inflammatory protein 1-α or coagulation dysfunction in patients with severe COVID-19 may increase the likelihood of stroke compared with moderate patients [200].